Sepsis & infection

Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study

Ann Intensive CarePublished Pre-post quasi-experimental study

Authors' conclusion

The institution of a MMT allowed for an optimization of antimicrobial treatments, reflecting to a significant decrease in new MDRO colonization and microbiological failure among critically ill patients.

Study context

Population
Critically ill ICU patients with Gram-negative bloodstream infection
Participants
135 patients
Comparison
Post-intervention vs Pre-intervention
  • Post-interventionn = 68
  • Pre-interventionn = 67reference
Outcome
Microbiological failure and new-onset 30-day MDRO colonization
Follow-up
30 days

Main finding

As reported in the abstract

Microbiological failure, post-phase vs pre-phase

10.3% vs. 29.9%

p = 0.005

New-onset 30-day multidrug-resistant organisms (MDRO) colonization, post-phase vs pre-phase

8.3% vs. 36.6%

p < 0.001

Multidisciplinary management team (MMT) protective for new MDRO colonization (multivariable OR, 95%CI)

OR 0.17, 95%CI

0.05–0.67

MMT protective for microbiological failure (multivariable OR, 95%CI)

OR 0.37, 95%CI

0.14–0.98

Further findings

Empirical carbapenem administration

Decreased significantly in the post-phase
40.3% vs. 62.7%, p = 0.02

Appropriate empirical therapy

Increased in the post-phase
86.9% vs. 55.2%, p < 0.001

Overall antibiotic treatment duration

Decreased in the post-phase (days)
12 vs. 16 days, p < 0.001

Delta SOFA and all-cause 30-day mortality

No differences

Original publication

Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study. Ann Intensive Care. Published 6 March 2024. doi:10.1186/s13613-024-01271-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.